322 related articles for article (PubMed ID: 34927450)
1. Machine Learning Approach to Classify Cardiovascular Disease in Patients With Nonalcoholic Fatty Liver Disease in the UK Biobank Cohort.
Sharma D; Gotlieb N; Farkouh ME; Patel K; Xu W; Bhat M
J Am Heart Assoc; 2022 Jan; 11(1):e022576. PubMed ID: 34927450
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular disease risk prediction using automated machine learning: A prospective study of 423,604 UK Biobank participants.
Alaa AM; Bolton T; Di Angelantonio E; Rudd JHF; van der Schaar M
PLoS One; 2019; 14(5):e0213653. PubMed ID: 31091238
[TBL] [Abstract][Full Text] [Related]
3. Behavioural activity pattern, genetic factors, and the risk of nonalcoholic fatty liver disease: A prospective study in the UK Biobank.
Ge X; Wang X; Yan Y; Zhang L; Yu C; Lu J; Xu X; Gao J; Liu M; Jiang T; Ke B; Song C
Liver Int; 2023 Jun; 43(6):1287-1297. PubMed ID: 37088982
[TBL] [Abstract][Full Text] [Related]
4. Fatty Liver Index and Development of Cardiovascular Disease: Findings from the UK Biobank.
Zou B; Yeo YH; Cheung R; Ingelsson E; Nguyen MH
Dig Dis Sci; 2021 Jun; 66(6):2092-2100. PubMed ID: 33782808
[TBL] [Abstract][Full Text] [Related]
5. Comparison and development of advanced machine learning tools to predict nonalcoholic fatty liver disease: An extended study.
Liu YX; Liu X; Cen C; Li X; Liu JM; Ming ZY; Yu SF; Tang XF; Zhou L; Yu J; Huang KJ; Zheng SS
Hepatobiliary Pancreat Dis Int; 2021 Oct; 20(5):409-415. PubMed ID: 34420885
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic fatty liver disease and cardiovascular disease.
Hyogo H; Chayama K; Yamagishi S
Curr Pharm Des; 2014; 20(14):2403-11. PubMed ID: 23844815
[TBL] [Abstract][Full Text] [Related]
7. Predicting the 5-Year Risk of Nonalcoholic Fatty Liver Disease Using Machine Learning Models: Prospective Cohort Study.
Huang G; Jin Q; Mao Y
J Med Internet Res; 2023 Sep; 25():e46891. PubMed ID: 37698911
[TBL] [Abstract][Full Text] [Related]
8. A healthy lifestyle, Life's Essential 8 scores and new-onset severe NAFLD: A prospective analysis in UK Biobank.
He P; Zhang Y; Ye Z; Li H; Liu M; Zhou C; Yang S; Gan X; Zhang Y; Qin X
Metabolism; 2023 Sep; 146():155643. PubMed ID: 37380018
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of machine learning models for nonalcoholic fatty liver disease.
Peng HY; Duan SJ; Pan L; Wang MY; Chen JL; Wang YC; Yao SK
Hepatobiliary Pancreat Dis Int; 2023 Dec; 22(6):615-621. PubMed ID: 37005147
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic Fatty Liver Disease (NAFLD)-A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients.
Mikolasevic I; Milic S; Racki S; Zaputovic L; Stimac D; Radic M; Markic D; Orlic L
Perit Dial Int; 2016; 36(4):427-32. PubMed ID: 26475841
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: a Review of Shared Cardiometabolic Risk Factors.
Muzurović E; Peng CC; Belanger MJ; Sanoudou D; Mikhailidis DP; Mantzoros CS
Hypertension; 2022 Jul; 79(7):1319-1326. PubMed ID: 35465684
[TBL] [Abstract][Full Text] [Related]
12. Non-Alcoholic Fatty Liver Disease and Vascular Disease.
Forlano R; Mullish BH; Nathwani R; Dhar A; Thursz MR; Manousou P
Curr Vasc Pharmacol; 2021; 19(3):269-279. PubMed ID: 32188385
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease.
Luo J; Xu L; Li J; Zhao S
Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):193-9. PubMed ID: 25563143
[TBL] [Abstract][Full Text] [Related]
14. Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: Data from the ATTICA cohort study.
Kouvari M; Polyzos SA; Chrysohoou C; Skoumas J; Pitsavos CS; Panagiotakos DB; Mantzoros CS
Clin Nutr; 2022 Jun; 41(6):1281-1289. PubMed ID: 35504171
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic Fatty Liver Disease (NAFLD) and Cardiovascular Risk: Is Imaging Helpful?
Doumas SA; Tripathi S; Kashikar A; Khuttan A; Kumar A; Singh H; Canakis JP; Ashish K; Dey D; Oppenheim I; Dey AK
Curr Probl Cardiol; 2024 Jan; 49(1 Pt B):102065. PubMed ID: 37652112
[TBL] [Abstract][Full Text] [Related]
16. Early Predictors of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease: Non-obese Versus Obese Patients.
Shao C; Ye J; Li F; Lin Y; Wu T; Wang W; Feng S; Zhong B
Dig Dis Sci; 2020 Jun; 65(6):1850-1860. PubMed ID: 31724099
[TBL] [Abstract][Full Text] [Related]
17. Synergistic increase in cardiovascular risk in diabetes mellitus with nonalcoholic fatty liver disease: a meta-analysis.
Zhou YY; Zhou XD; Wu SJ; Hu XQ; Tang B; Poucke SV; Pan XY; Wu WJ; Gu XM; Fu SW; Zheng MH
Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):631-636. PubMed ID: 29351115
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases.
Cai J; Zhang XJ; Ji YX; Zhang P; She ZG; Li H
Circ Res; 2020 Feb; 126(5):679-704. PubMed ID: 32105577
[TBL] [Abstract][Full Text] [Related]
19. Reversal of nonalcoholic fatty liver disease reduces the risk of cardiovascular disease among Korean.
Oh YH; Jeong S; Park SJ; Ahn JC; Park SM
Medicine (Baltimore); 2023 Nov; 102(44):e35804. PubMed ID: 37933021
[TBL] [Abstract][Full Text] [Related]
20. Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases.
Motamed N; Rabiee B; Poustchi H; Dehestani B; Hemasi GR; Khonsari MR; Maadi M; Saeedian FS; Zamani F
Clin Res Hepatol Gastroenterol; 2017 Feb; 41(1):31-38. PubMed ID: 27597641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
